Results 61 to 70 of about 74,841 (314)
Toxins, 2021 At least 40 toxin subtypes of botulinum neurotoxins (BoNTs), a heterogenous group of bacterial proteins, are produced by seven different clostridial species.
Theresa J. Smith +6 more
doaj +1 more source
, 2022 Rod Clostridium čine sporogene, gram-pozitivne, anaerobne štapićaste bakterije. Pripadnici ovog roda imaju industrijski i medicinski značaj, obzirom da proizvode opasne toksine. Vrsta Clostridium botulinum široko je rasprostranjena, a proizvodi najotrovniji poznati toksin, botulinski neurotoksin, koji zbog jedinstvenih farmakoloških obilježja ima ...
openaire +2 more sources
Uso da toxina botulínica no controle do bruxismo [PDF]
, 2014 TCC (graduação) - Universidade Federal de Santa Catarina. Centro de Ciências da Saúde. Odontologia.A toxina botulínica é uma substância produzida pela bactéria Clostridium botulinum, e o seu uso oferece ao cirurgião dentista uma nova alternativa para ...
Francescon, Ariane
core
JEADV Clinical Practice, EarlyView.ABSTRACT Background Residual limb hyperhidrosis (RLH) is a frequent and debilitating condition among lower‐limb prosthetic users. Although aluminium chloride is recommended first‐line for focal hyperhidrosis, its efficacy in RLH has not previously been evaluated in prospective studies.
Jette Schack +3 more
wiley +1 more source
Cervical Inlet Patches in R‐CPD: An Unrecognized Predictor of Treatment Failure
The Laryngoscope, EarlyView.This retrospective cohort study identified cervical inlet patches (CIP) in 19.8% of patients undergoing cricopharyngeal botulinum toxin injection for R‐CPD. CIP presence and increasing age independently predicted failure to sustain a long‐term treatment response, suggesting that CIP may be an underrecognized factor in R‐CPD treatment durability ...
Andrew Geoffrey Tritter +2 more
wiley +1 more source
Update on Non-Interchangeability of Botulinum Neurotoxin Products
ToxinsThe growing use of botulinum neurotoxins (BoNTs) for medical and aesthetic purposes has led to the development and marketing of an increasing number of BoNT products.
Mitchell F. Brin +4 more
doaj +1 more source
Capsaicin protects neuromuscular junctions from the inhibitory effects of botulinum neurotoxin A [PDF]
, 2008 Within 24 hrs after injecting botulinum neurotoxin A (BoNT/A) into the hindlimb, mice lost the toe spread reflex and developed progressive muscle weakness. At the same time, the compound muscle action potential amplitude decreased. Injection of capsaicin
Carmen Garcia +5 more
core
Pitch Strength & Percent Vocal Creak to Assess Treatment Response in Adductor Laryngeal Dystonia
The Laryngoscope, EarlyView.Pitch Strength (PS) and Percent Vocal Creak (%VC) were measured before and after botulinum neurotoxin treatment in patients with adductor laryngeal dystonia (AdLD). While PS and %VC correlated with changes in disruption frequency and perceptual severity, they did not demonstrate robust group‐level treatment sensitivity.
Jesse D. Hoffmeister +5 more
wiley +1 more source
The Effectiveness of Botulinum Toxin Type A Injections in the Management of Sialorrhea [PDF]
, 2018 Objective: The aim of this study was to evaluate the effect of Botulinum toxin type A by injecting in the submandibular and parotid glands on the frequency and severity of sialorrhea.Methods: Pediatric patients who were referred to our department with ...
Özgür Tarkan +6 more
core +1 more source
Report of Adverse Events Associated With Cutaneous Procedures: Update From the CAPER Registry
Lasers in Surgery and Medicine, EarlyView.ABSTRACT Objectives To systematically evaluate submissions to the CAPER database by analyzing procedural context, characteristics of reported adverse events (AEs), and provider involvement in order to identify patterns with potential implications for patient safety.
Sabrina S. Smith +9 more
wiley +1 more source